Cargando…

Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator

AIMS: Atrial fibrillation (AF) and heart failure are conditions that often coexist. Consequently, many patients with an implantable cardioverter-defibrillator (ICD) present with AF. We evaluated the effectiveness of internal cardioversion of AF in patients with an ICD. METHODS: Retrospectively, we i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Limantoro, I., Vernooy, K., Weijs, B., Pisters, R., Debie, L., Crijns, H. J., Blaauw, Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2013
Materias:	Original Article-E-Learning
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833915/ https://www.ncbi.nlm.nih.gov/pubmed/24092363 http://dx.doi.org/10.1007/s12471-013-0474-z

Ejemplares similares

Internal cardioversion of persistent atrial fibrillation in implantable cardioverter defibrillator patients: the juice is not worth the squeeze
por: Berger, W. R., et al.
Publicado: (2013)

Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy
por: van Welsenes, G. H., et al.
Publicado: (2010)

Driving restrictions for Dutch patients with an implantable cardioverter defibrillator: Compliance and associated factors
por: Jongejan, N., et al.
Publicado: (2017)

Optimal long-term antithrombotic management of atrial fibrillation: life cycle management
por: Pisters, R., et al.
Publicado: (2018)

Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit?
por: Wijers, S. C., et al.
Publicado: (2013)

Programmed inappropriate ICD ventricular defibrillation for cardioversion of persistent atrial fibrillation
por: Korantzopoulos, Panagiotis, et al.
Publicado: (2008)

Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)

Real-life use of Rivaroxaban in the Netherlands: data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry
por: Pisters, R., et al.
Publicado: (2017)

Dual‐chamber implantable cardioverter–defibrillator. Is it useful in patient with permanent atrial fibrillation?
por: Porres‐Aracama, José M., et al.
Publicado: (2016)

Defining the benefit: Cardioversion of persistent atrial fibrillation
por: Nedios, Sotirios, et al.
Publicado: (2021)

Implantable Cardioverter-Defibrillator Implantation in a Patient with Atrial Standstill
por: Park, So Ra, et al.
Publicado: (2009)

Defibrillation threshold of internal cardioversion prior to ablation predicts atrial fibrillation recurrence
por: Sawasaki, Kohei, et al.
Publicado: (2021)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Prognostic significance of incident atrial fibrillation following STEMI depends on the timing of atrial fibrillation
por: Gal, P., et al.
Publicado: (2015)

QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation
por: Younis, Arwa, et al.
Publicado: (2022)

Diagnosis of atrial fibrillation in heart failure patients with implantable cardioverter defibrillator or cardiac resynchronisation therapy
por: Dominik, Barbara, et al.
Publicado: (2021)

Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation
por: Van Noord, Trudeke, et al.
Publicado: (2005)

Atrial fibrillation detection using the ECG signal in the left in ear region: validation study on patients electively admitted for DC cardioversion
por: De Lucia, R, et al.
Publicado: (2023)

Atrial pacing–induced oversensing in subcutaneous implantable cardioverter-defibrillator
por: Wharmby, Amy, et al.
Publicado: (2023)

Comparison and predictors of implantable cardioverter-defibrillator therapy for primary and secondary prevention
por: Evertz, Reinder, et al.
Publicado: (2023)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Feasibility and Efficacy of His Bundle Pacing or Left Bundle Pacing Combined With Atrioventricular Node Ablation in Patients With Persistent Atrial Fibrillation and Implantable Cardioverter‐Defibrillator Therapy
por: Wang, Songjie, et al.
Publicado: (2019)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Idiopathic atrial fibrillation patients rapidly outgrow their low thromboembolic risk: a 10-year follow-up study
por: Weijs, B., et al.
Publicado: (2019)

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
por: ten Cate, V., et al.
Publicado: (2016)

The extravascular implantable cardioverter-defibrillator: characterization of anatomical parameters impacting substernal implantation and defibrillation efficacy
por: Molnár, Levente, et al.
Publicado: (2021)

Inappropriate sensing events revealing electrocautery-induced implantable cardioverter–defibrillator lead failure
por: Can, İlknur, et al.
Publicado: (2015)

Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator
por: Karnik, Ankur A., et al.
Publicado: (2017)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Cardiac Magnetic Resonance Imaging–Derived Left Atrial Characteristics in Relation to Atrial Fibrillation Detection in Patients With an Implantable Cardioverter‐Defibrillator
por: Hopman, Luuk H. G. A., et al.
Publicado: (2023)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Intraoperative defibrillation threshold testing and postoperative long-term efficacy of cardioverter-defibrillator implantation
por: GAN, TIANYI, et al.
Publicado: (2013)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Clinical utility of rhythm control by electrical cardioversion to assess the association between self-reported symptoms and rhythm status in patients with persistent atrial fibrillation
por: Hermans, Astrid N.L., et al.
Publicado: (2021)

Electrical injury‐induced ventricular fibrillation documented and treated with an implantable cardioverter defibrillator
por: Higami, Shigeo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_slssbbo4i6vf5562qukcsi097c